Novartis Self-Medication second-tier management announced by Ciba/Sandoz.
This article was originally published in The Tan Sheet
Executive Summary
NOVARTIS SELF-MEDICATION U.S. "MANAGEMENT TEAM" SELECTED as the pending merger between Ciba-Geigy and Sandoz draws closer, the firms announced June 26. Of the seven VP-level appointments, four are from Sandoz Consumer Pharmaceuticals Corporation and three are from Ciba Self-Medication. All appointed VPs will report directly to Fred Huser, president-designate of Novartis Self-Medication, the companies stated. Huser was chosen to head the combined companies' OTC business in May ("The Tan Sheet" May 13, p. 6).